BANNOCKBURN, Ill. , Dec. 14, 2011 /PRNewswire/ – Pinnacle Biologics, Inc., a privately held specialty bio-pharmaceutical company announced today that it has obtained approval for an Orphan Drug Designation (ODD) for their product PHOTOFRIN …

View full post on mesothelioma – Bing News